TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Senate committee approves Lester Crawford’s nomination for FDA Commissioner. June 17, 2005
TCL Archive Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal. February 17, 2006
